Experience in diagnosis and treatment of prolactinomas in pediatric patients and young adults

Endocrinol Diabetes Nutr (Engl Ed). 2022 Dec;69(10):911-913. doi: 10.1016/j.endien.2022.11.028. Epub 2022 Nov 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Child
  • Dopamine Agonists / therapeutic use
  • Humans
  • Pituitary Neoplasms* / diagnosis
  • Pituitary Neoplasms* / therapy
  • Prolactinoma* / diagnosis
  • Prolactinoma* / therapy
  • Young Adult

Substances

  • Dopamine Agonists